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A B S T R A C T   
Ten human induced pluripotent stem cell (iPSC) lines have been derived from five healthy controls matched to a study including Attention-Deficit Hyperactivity 
Disorder patients (ADHD). Both female and male children and adolescents aged 6–18 years were recruited. Isolated keratinocyte cells from the participants were 
reprogrammed into iPSCs using non-integrating Sendai virus to deliver the reprogramming factors Oct3/4, Sox2, Klf4 and cMyc.   
1. Resource table:  












Alternative names of stem 
cell lines 
KO-001 c6 (TMPi001-A)  
KO-001 c9 (TMPi001-B)  
KO-003 c14 (TMPi002-A)  
KO-003 c20 (TMPi002-B)  
KO-005 c12 (TMPi003-A)  
KO-005 c13 (TMPi003-B)  
KO-008 c13 (TMPi004-A)  
KO-008 c44 (TMPi004-B)  
KO-011 c6 (TMPi005-A)  
KO-011 c10 (TMPi005-B) 
Institution Psychiatric University Hospital Zurich, Department of 
Child and Adolescent Psychiatry and Psychotherapy, 
University of Zurich. 
Contact information of 
distributor 
Prof. Dr. Edna Grünblatt (edna.gruenblatt@kjpd.uzh. 
ch) 
(continued on next column)  
(continued ) 
Type of cell lines iPSC 
Origin Human 
Cell Source Keratinocytes 
Clonality Clonal 
Method of reprogramming Sendai virus transduction 
Multiline rationale Control and disease pair (Grossmann et al., 2021) 
Gene modification NO 
Type of modification N/A 
Associated disease Healthy controls 
Gene/locus N/A 
Method of modification N/A 






Date archived/stock date March 2020 
Cell line repository/bank N/A 
Ethical approval Cantonal Ethics Committee (BASEC-Nr.-2016-00101 & 
BASEC-Nr.-201700825)  
2. Resource utility 
Induced pluripotent stem cells (iPSCs) are a powerful tool in disease 
modelling by maintaining the genetic background from somatic cells of 
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individuals. Molecular and cellular analysis using iPSC-derived neural 
cells allows to elucidate differences between patients (e.g. ADHD) and 
healthy controls after iPSC generation and characterization to guarantee 
viable and trustworthy research. 
3. Resource details 
ADHD is one of the most complex and heterogeneous neuro-
developmental disorders, with a worldwide prevalence of over 5% and a 
high heritability rate of 80% (Polanczyk et al., 2007). Disease modelling 
through iPSCs derived from ADHD patients is crucial to understand the 
underlying molecular mechanisms involved in ADHD and establishing 
matching control lines is equally important for such research develop-
ment. In this paper, iPSC lines from five healthy controls were generated 
using the non-integrative Sendai virus (SeV) transduction. These control 
cell lines match the ADHD cell lines reported by Grossmann and col-
leagues (Grossmann et al., 2021). 
Keratinocytes from plucked hair were used as primary source for 
reprogramming (Table 1). The characterization of the derived iPSC lines 
is summarized in Table 2. By phase contrast microscopy, iPSC lines 
showed formation of well-delimited colonies, formed by small round 
cells with high nucleus:cytoplasm ratio (Fig. 1A, LM: light microscopy, 
scale bar: 200 µm). To biologically characterize the lines as pluripotent 
cells, gene and protein expression of pluripotency markers was also 
assessed through quantitative real-time PCR (qRT-PCR) and immuno-
cytochemistry assays, respectively. All cell lines exhibited OCT4, SOX2, 
SSEA4 and TRA-1-60 expression in the latter (Fig. 1A, LM: light micro-
scopy, scale bar: 200 µm) and positive expression of LIN28A, NANOG, 
OCT4 and SOX2 in the former (Fig. 1E). Additionally, possible myco-
plasma contamination was assessed in a conventional PCR and demon-
strated negative detection. The 1.2% agarose gel was cropped to 
separate controls from ADHD lines tested at the same time (Fig. 1B). All 
iPSCs were analysed regarding their potential to become embryoid 
bodies (EBs) (Fig. 1A, LM: light microscopy, scale bar: 200 µm) and their 
Table 1 
Summary of lines.  
iPSC line names Abbreviation in figures Gender Age Ethnicity Genotype of locus Disease 
TMPi001-A KO-001 c6 Male 15 Caucasian N/A Healthy controls 
TMPi001-B KO-001 c9 Male 15 Caucasian N/A Healthy controls 
TMPi002-A KO-003 c14 Female 10 Caucasian N/A Healthy controls 
TMPi002-B KO-003 c20 Female 10 Caucasian N/A Healthy controls 
TMPi003-A KO-005 c12 Male 16 Caucasian N/A Healthy controls 
TMPi003-B KO-005 c13 Male 16 Caucasian N/A Healthy controls 
TMPi004-A KO-008 c13 Female 8 Caucasian N/A Healthy controls 
TMPi004-B KO-008 c44 Female 8 Caucasian N/A Healthy controls 
TMPi005-A KO-011 c6 Male 16 Caucasian N/A Healthy controls 
TMPi005-B KO-011 c10 Male 16 Caucasian N/A Healthy controls  
Table 2 
Characterization and validation.  
Classification Test Result Data 
Morphology Light microscopy Normal morphology in which iPSCs show round morphology, 
aggregation in colonies with well-delimited borders 
Fig. 1, panel A 
Phenotype Qualitative analysis by immunocytochemistry Positive protein expression of pluripotency markers (OCT4, 
SOX2, SSEA4, and TRA-1-60) 
Fig. 1, panel A 
Quantitative analysis Positive expression of pluripotency genes (LIN28, NANOG, 
OCT4 and SOX2) 
Fig. 1, panel E 
Genotype Genetic integrity analysis between saliva and iPSC DNA 
CNVs using genome-wide association array 
KO-001 c6: 46XY 
KO-001 c9: 46XY 
KO-003 c14: 46XX 
KO-003 c20: 46XX 
KO-005 c12: 46XY 
KO-005 c13: 46XY 
KO-008 c13: 46XX 
KO-008 c44: 46XX 
KO-011 c6: 46XY 
KO-011 c10: 46XY 
Fig. 1, panel C and 
supplementary 
Identity Infinium global screening array (Illumina) N/A N/A 
N/A Submitted in archive 
with journal 
Mutation analysis (IF 
APPLICABLE) 
Sequencing N/A N/A 
Southern Blot OR WGS N/A N/A 
Microbiology and 
virology 
Mycoplasma Negative Fig. 1, item B 
Differentiation potential Embryoid body Embryoid body formation from all cell lines with positive 
expression of AFP (endoderm), SOX2 (ectoderm) and FLK1 
(mesoderm) 
Fig. 1, panels A and F 
Donor screening 
(OPTIONAL) 
HIV 1 + 2 Hepatitis B, Hepatitis C N/A N/A 
Genotype additional info 
(OPTIONAL) 
Saliva genotyping DNA analysis Not shown but available 
with author 
HLA tissue typing N/A N/A  
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potential to differentiate into the three germ layers (ectoderm, meso-
dermal and endoderm) by expression analysis of specific markers 
(Fig. 1F). Regular karyograms without significant genomic aberrations 
were also obtained to prove that the reprogramming process has not 
compromised our study (Fig. 1C shows K001 i6; see supplementary file 
for all lines). Possible remaining SeV was verified by qRT-PCR and 
demonstrated that the only cell line with minimal SeV traces (relative 
expression = 0.22%) was K003 c14, compared to the positive control 
(P1 iPSC) (relative expression = 100%) (Fig. 1D). The negative control 
(control iPSC) showed no expression, as expected (Fig. 1D). 
4. Materials and methods 
4.1. Subject recruitment 
Two female and three male healthy individuals have been recruited 
by the Department of Child and Adolescent Psychiatry and Psycho-
therapy, University Hospital of Psychiatry Zurich, University of Zurich, 
to be part of a disease modelling study of ADHD (Grossmann et al., 
2021). In contrast with ADHD patients, healthy controls did not show 
any psychiatric disorder, according to ICD-10 or DSM-5 (see details 
under supplementary material). 
4.2. Reprogramming 
Patient-specific keratinocytes were used as primary source for iPSCs 
generation by Sendai virus transduction (CytoTuneTM-iPS 2.0 kit by 
Invitrogen – Thermo Fisher Scientific), carrying polycistronic Klf4-Oct3/ 
4-Sox2 (KOS), cMyc and Klf4. The reprogramming protocol was per-
formed according to Re et al. (2018). 
Generated iPSCs were cultivated on Vitronectin-coated wells in E8 
medium and passaged every 3–4 days at a 1:3 ratio by Versene (Gibco). 
The iPSCs were expanded until at least passage 10 for quality control 
(QC). 
4.3. Immunocytochemistry 
Protein expression of OCT4, SSEA4, TRA-1-60 and SOX2 was 
assessed by the Pluripotent Stem Cell 4-Marker Immunocytochemistry 
Kit (InvitrogenTM), according to the manufacturer’s instructions. Anti-
bodies used are listed in Table 3. 
4.4. Real-time quantitative PCR analysis 
Expression of pluripotency genes was determined by qRT-PCR using 
the QuantiFast® SYBR® Green PCR kit (Qiagen) from cDNA. RNA was 
extracted from iPSCs using the RNeasy® Plus Mini kit (Qiagen) and 
reverse transcription from 500 ng RNA into cDNA was performed by 
iScriptTM cDNA Synthesis Kit (Bio-Rad). cDNA production and amplifi-
cation of genes of interest (GOIs) and reference genes (RGs) were per-
formed on the CFX384 thermal cycler using the primers detailed in 
Table 3. PCR efficiency was calculated by LinRegPCR (version 
2020.0.0.3), while normalization of GOIs’ mRNA levels in relation to 
RGs was accomplished by Biogazelle qBasePLUS2 software (version 2.3) 
(ACTB and HMBS for iPSCs, ACTB and GAPDH for EBs). The heatmap 
plot was generated by the package heatmap3 in RStudio (version 
1.1.423). 
Fig. 1. Quality control of generated induced pluripotent stem cells (iPSCs) from 10 control lines. A) Light microscopy images showing morphology of all iPSCs (first 
column) and positive expression of pluripotent markers (OCT4, SSEA4, TRA-1-60 and SOX2) by immunocytochemistry (second and third column). Embryoid Bodies 
(EBs) morphology is also displayed (fourth column). B) Absence of mycoplasma in the supernatant of all iPSCs was demonstrated in an 1.2% agarose gel following 
DNA amplification by conventional PCR. C) Possible genetic aberrations caused by the reprogramming process were absent, as represented by the karyotype from 
KO-001 c6 (TMPi001-A) (for all lines see supplementary material). D) Sendai virus traces in culture were assessed by quantitative real time PCR (qRT-PCR) and 
compared to a positive control (P1 iPSC). E) Hierarchical gene expression analysis of pluripotency genes between iPSC lines, assessed by qRT-PCR. F) Hierarchical 
gene expression of endodermal (AFP), mesodermal (FLK1) and ectodermal (SOX2) markers in EBs, assessed by qRT-PCR. 
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4.5. Detection of SeV genome 
Presence of possible remaining SeV was tested in culture by using 
SeV primers in qRT-PCR (Table 3). RNA from an iPSC at passage one and 
a commercial human episomal iPSC line (A18945, Thermo Fisher Sci-
entific) were used as positive and negative controls, respectively. 
4.6. Mycoplasma testing 
Possible mycoplasma contamination was assessed in the supernatant 
of iPSCs at passage eleven and above by the LookOut Mycoplasma PCR 
Detection Kit (Sigma-Aldrich), according to manufacturer’s instructions. 
C1000TM/CFX96TM Thermal Cycler was used for DNA amplification and 
amplicons were loaded on a 1.2% agarose gel containing HDGreen Plus 
(INTAS, Germany) and run at 100 V for 30 min. The negative internal 
control sample showed a band at 480 bp, while positive bands were 
expected at 260 bp. 
4.7. Generation of embryoid bodies (EBs) 
EBs were formed after iPSC culture in AggreWells with E8/PVA 
medium for 48 h (Lin and Chen, 2014). RNA extraction was then per-
formed and 1 μg RNA was used for expression analysis of specific 
markers (Table 3). 
4.8. Genotyping analysis 
DNA from saliva and iPSCs were individually extracted with the 
GeneFixTM saliva-Prep DNA kit (Isohelix) and DNeasy® Blood & Tissue 
kit (Qiagen), respectively. Samples were sent for genotyping with 
Infinium Global Screening Array (GSA, Illumina). Analysis and com-
parison between the genotypes were made with the Genome Viewer 
function from the GenomeStudio software (version 2.0). 
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Table 3 
Reagents details.  
Antibodies used for immunocytochemistry/flow-citometry  
Antibody Dilution Company Cat # and RRID 
Pluripotency Markers Rabbit anti-OCT4 1:200 Thermo Fisher Scientific Cat# A24867, RRID: AB_2650999 
Pluripotency Markers Mouse IgG3 anti-SSEA4 1:100 Thermo Fisher Scientific Cat# A24866, RRID: AB_2651001 
Pluripotency Markers Rat anti-SOX2 1:100 Thermo Fisher Scientific Cat# A24759, RRID: AB_2651000 
Pluripotency Markers Mouse IgM anti-TRA-1-60 1:100 Thermo Fisher Scientific Cat# A24868, RRID: AB_2651002 
Secondary antibodies Alexa Fluor™ 555 donkey anti-rabbit 1:250 Thermo Fisher Scientific Cat# A24869, RRID: AB_2651006 
Secondary antibodies Alexa Fluor™ 488 goat anti-mouse IgG3 1:250 Thermo Fisher Scientific Cat# A24877, RRID: AB_2651008 
Secondary antibodies Alexa Fluor™ 488 donkey anti-rat 1:250 Thermo Fisher Scientific Cat# A24876, RRID: AB_2651007 
Secondary antibodies Alexa Fluor™ 555 goat anti-mouse IgM 1:250 Thermo Fisher Scientific Cat# A24871, RRID: AB_2651009  
Primers  
Target Forward/Reverse primer (5′-3′) 
Pluripotency Markers (qPCR) Sendai Virus (SeV) F: GGATCACTAGGTGATATCGAGC 
R: ACCAGACAAGAGTTTAAGAGTATGTATC 
Pluripotency Markers (qPCR) LIN28A F: AGCGCAGATCAAAAGGAGACA 
R: CCTCTCGAAAGTAGGTTGGCT 
Pluripotency Markers (qPCR) OCT4 F: GGAGGAAGCTGACAACAATGAAA 
R: GGCCTGCACGAGGGTTT 
Pluripotency Markers (qPCR) NANOG F: TACCTCAGCCTCCAGCAGAT 
R: CTTCTGCGTCACACCATTGC 
Pluripotency and Embryoid Body Markers (qPCR) SOX2 F: TGCGAGCGCTGCACAT 
R: TCATGAGCGTCTTGGTTTTCC 
Embryoid Body Markers (qPCR) AFP F: AAATGCGTTTCTCGTTGCTT 
R: GCCACAGGCCAATAGTTTGT 
Embryoid Body Markers (qPCR) FLK1 F: TGATCGGAAATGACACTGGA 
R: CACGACTCCATGTTGGTCAC 
House-Keeping Genes (qPCR) HMBS According to manufacturer Qiagen 249,900 
(QT00014462) 
House-Keeping Genes (qPCR) ACTB According to manufacturer Qiagen 249,900 
(QT00095431) 
House-Keeping Genes (qPCR) GAPDH According to manufacturer Qiagen 249,900 
(QT00079247)  
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